High-purity preparation of HSV-2 vaccine candidate ACAM529 is immunogenic and efficacious in vivo.

by Sophia T Mundle, Hector Hernandez, John Hamberger, John Catalan, Changhong Zhou, Svetlana Stegalkina, Andrea Tiffany, Harry Kleanthous, Simon Delagrave, Stephen F Anderson
Published 2013-01-01